awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30590270-2C4BEFA6-CE3E-4DFF-983E-06C8438BF09B
Q30590270-2C4BEFA6-CE3E-4DFF-983E-06C8438BF09B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30590270-2C4BEFA6-CE3E-4DFF-983E-06C8438BF09B
Strategies for modern biomarker and drug development in oncology.
P2860
Q30590270-2C4BEFA6-CE3E-4DFF-983E-06C8438BF09B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30590270-2C4BEFA6-CE3E-4DFF-983E-06C8438BF09B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1eeaab997fea3f48a139a8b29e8ed40d4091d27d
P2860
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.